Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis-Reference-Cited by-同舟云学术

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Published:2024-02 Issue:2 Volume:6 Page:e1053
ISSN:2639-8028
Container-title:Critical Care Explorations
language:en
Short-container-title:

Author:

Vaara Suvi T.¹,Serpa Neto Ary,Bellomo Rinaldo²³,Adhikari Neill K. J.,Dreyfuss Didier⁴⁵,Gallagher Martin⁶⁷,Gaudry Stephane⁴⁸,Hoste Eric⁹,Joannidis Michael¹⁰,Pettilä Ville¹,Wang Amanda Y.⁶⁷¹¹,Kashani Kianoush¹²,Wald Ron¹³¹⁴,Bagshaw Sean M.¹⁵,Ostermann Marlies¹⁶,

Affiliation:

1. Department of Perioperative and Intensive Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

2. Data Analytics Research & Evaluation, Austin Hospital, Melbourne, VIC, Australia.

3. Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.

4. French National Institute of Health and Medical Research (INSERM), UMR_S1155, CORAKID, Hôpital Tenon, Sorbonne Université, Paris, France.

5. Service de Médecine Intensive Réanimation, Hôpital Louis Mourier, Assistance Publique, Université de Paris-Cité, Paris, France.

6. South Western Sydney Clinical Campus, Faculty of Medicine & Health, University of New South Wales, New South Wales, NSW, Australia.

7. The George Institute for Global Health, University of New South Wales, New South Wales, Australia.

8. AP-HP, Hôpital Avicenne, Service de Réanimation Médico-Chirurgicale, UFR SMBH, Université Sorbonne Paris Nord, Bobigny, France.

9. Intensive Care Unit, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium.

10. Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.

11. The Faculty of Medicine and Medical Sciences, Macquarie University, Sydney, NSW, Australia.

12. Division of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN.

13. Medicine Program and Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON, Canada.

14. Division of Nephrology, St. Michael’s Hospital and the University of Toronto and the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, ON, Canada.

15. Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, AB, Canada.

16. Department of Critical Care Medicine, King’s College London, Guy’s & St Thomas’ Hospital, London, United Kingdom.

Abstract

OBJECTIVES: Among patients with severe acute kidney injury (AKI) admitted to the ICU in high-income countries, regional practice variations for fluid balance (FB) management, timing, and choice of renal replacement therapy (RRT) modality may be significant. DESIGN: Secondary post hoc analysis of the STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial (ClinicalTrials.gov number NCT02568722). SETTING: One hundred-fifty-three ICUs in 13 countries. PATIENTS: Altogether 2693 critically ill patients with AKI, of whom 994 were North American, 1143 European, and 556 from Australia and New Zealand (ANZ). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Total mean FB to a maximum of 14 days was +7199 mL in North America, +5641 mL in Europe, and +2211 mL in ANZ (p < 0.001). The median time to RRT initiation among patients allocated to the standard strategy was longest in Europe compared with North America and ANZ (p < 0.001; p < 0.001). Continuous RRT was the initial RRT modality in 60.8% of patients in North America and 56.8% of patients in Europe, compared with 96.4% of patients in ANZ (p < 0.001). After adjustment for predefined baseline characteristics, compared with North American and European patients, those in ANZ were more likely to survive to ICU (p < 0.001) and hospital discharge (p < 0.001) and to 90 days (for ANZ vs. Europe: risk difference [RD], –11.3%; 95% CI, –17.7% to –4.8%; p < 0.001 and for ANZ vs. North America: RD, –10.3%; 95% CI, –17.5% to –3.1%; p = 0.007). CONCLUSIONS: Among STARRT-AKI trial centers, significant regional practice variation exists regarding FB, timing of initiation of RRT, and initial use of continuous RRT. After adjustment, such practice variation was associated with lower ICU and hospital stay and 90-day mortality among ANZ patients compared with other regions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference38 articles.

1. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis.;Barbar;N Engl J Med,2018

2. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: A systematic review and individual patient data meta-analysis of randomised clinical trials.;Gaudry;Lancet,2020

3. Initiation strategies for renal-replacement therapy in the intensive care unit.;Gaudry;N Engl J Med,2016

4. Net ultrafiltration prescription and practice among critically ill patients receiving renal replacement therapy: A multinational survey of critical care practitioners.;Murugan;Crit Care Med,2020

5. Renal outcomes according to renal replacement therapy modality and treatment protocol in the ATN and RENAL trials.;Naorungroj;Crit Care,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trials and the importance of usual care;Critical Care;2024-07-08

2. An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney disease;Expert Review of Molecular Diagnostics;2024-07-02